View
2
Download
0
Category
Preview:
Citation preview
Skin at risk NonePrevention of periwound skin breakdown;
Protection from maceration Protect vulnerable or damaged areas Refer to site protocol
Askina® Barrier FilmAskina® Barrier Cream
1 - 3 days
Refer to site protocol
Protection and moisturising care for extremely dry, irritated skin
Linovera®Prevention of Stage I pressure ulcers
NoneSkin at risk
Your Guide for Wound Care
* in case of peripheral arterial disease, do not hydrate the wound
Skin at risk
Epithelialising wound
Granulating wound
Moist fibrinous wound
Black necrotic wound (non-ischemic) *
Infected wound
Granulating to epithelialising wound
Fibrinous to granulating wound
Dry fibrinous wound
Wound description / stage of wound healing
None
None
Medium
Medium to high
Low
Medium to high
Low
Medium to high
Low
Promotion of epithelialisation
Exudate management Promotion of granulation
Removal of fibrinous tissue Exudate management
Removal of dry necrotic tissue
Reduction of bacterial load Exudate managementOdour control
Absorption of remaining exudate; Promotion of epithelialisation
Removal of fibrinous tissue Exudate management Promotion of granulation
Removal of fibrinous tissue Prevention of infection
Therapeutic goalLevel of exudate
Topical application of rich, allergy tested moisture lotion
Protection of newly formed tissue
Wound cleansing, moist environment, protection of newly formed tissue and of surrounding skin
Mechanical or surgical debridement if needed, wound cleansing, enhancing moist environment to promote autolytic debridement
Hydration of the wound with hydrogelMechanical or surgical debridement
Wound cleansing, prevent contamination from external bacteria, enhance moist wound environment
Wound cleansing, protection of newly formed tissue and of surrounding skin
Wound cleansing, enhancing moist environment to promote autolytic debridement
Mechanical or surgical debridement if needed, wound cleansing, hydration of the wound
Procedure / actions
Refer to site protocol
Wound cleansing and wound bed preparation
Trixo-Lind®
Topical application
N/A
Cavity Dressings
Cavity Dressings
Askina® Gel
Silver Dressings
Cavity Dressings
Cavity Dressings
Askina® Gel
Askina® Biofilm Transparent Askina® Derm
Askina® SilNetAskina® DresSilAskina® Transorbent®
Askina® Absorb+Askina® Foam
Askina® Gel
Silver Dressings
Askina® SilNetAskina® DresSilAskina® Hydro
Askina® SilNetAskina® Absorb+Askina® Foam
Askina® Gel
N/A
Bandage, tape
Askina® Pad Bandage, tape
Askina® SilNet Askina® Derm
Askina® CarbosorbAskina® Pad Bandage, tape
Bandage, tape
Askina® Pad Bandage, tape
Askina® SilNet Askina® Derm
Secondary wound dressing
twice daily or as required
Frequency of application
up to 7 days
1 - 3 days
daily
up to 3 days
daily
3 - 5 days
1 - 3 days
1 - 3 days
Frequency of change
Deep
Primary wound dressing
Superficial
B. Braun Australia Pty Ltd | Bella Vista NSW 2153 | Tel: 1800 251 705 | Fax: 1800 628 045 | www.bbraun.com.au | info.au@bbraun.com© 2014 B. Braun Australia Pty Ltd
Topical application of Essential Fatty acids Diminish friction and shearing forces
twice daily
N/A
Prontosan® Wound Irrigation SolutionProntosan® Wound Gel
Prontosan® Wound Irrigation SolutionProntosan® Wound Gel
Prontosan® Wound Irrigation SolutionProntosan® Wound Gel
Wound Antisepsis
Prontosan® Wound Irrigation SolutionProntosan® Wound Gel
Prontosan® Wound Irrigation SolutionProntosan® Wound Gel
Prontosan® Wound Irrigation SolutionProntosan® Wound Gel
Skin Cleansing
Recommended